Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amyloid neuropathy].

S Ikegawa1

  • 1First Department of Internal Medicine, Kumamoto University Medical School.

Rinsho Shinkeigaku = Clinical Neurology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Familial amyloidotic polyneuropathy (FAP) causes severe nerve damage due to transthyretin (TTR) amyloid deposition. Understanding FAP pathogenesis is crucial for developing effective treatments for this rare genetic disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report.

Calcified tissue international·2021
Same author

TDP-43 maintains chondrocyte homeostasis and alleviates cartilage degradation in osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

A population-based study identifies an association of THBS2 with intervertebral disc degeneration.

Osteoarthritis and cartilage·2019
Same author

Novel KIAA0753 mutations extend the phenotype of skeletal ciliopathies.

Scientific reports·2017
Same author

Response to Lefebvre et al.

Clinical genetics·2017
Same author

Genome-wide DNA methylation profile implicates potential cartilage regeneration at the late stage of knee osteoarthritis.

Osteoarthritis and cartilage·2016
Same journal

[Utility of acute-phase cerebral blood flow single photon emission computed tomography (SPECT) for evaluating the pathophysiology of Bickerstaff brainstem encephalitis with decorticate posturing].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Successful treatment with rituximab in unilateral relapsing primary CNS vasculitis: a ‍case report].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Clinical management of headache comorbid with functional neurological disorder].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Transient myoclonic state with asterixis related to COVID-19].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Let's present at a regional meeting].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Editor's Note].

Rinsho shinkeigaku = Clinical neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Context:

  • Familial amyloidotic polyneuropathy (FAP) is a severe, autosomal dominant systemic amyloidosis.
  • It primarily affects peripheral nerves, causing sensory and autonomic dysfunction.
  • Transthyretin (TTR) amyloid deposition is a hallmark of FAP.

Purpose:

  • To describe the pathological features of FAP neuropathy.
  • To investigate the role of variant TTR in amyloid deposition.
  • To explore potential mechanisms underlying nerve damage in FAP.

Summary:

  • FAP neuropathy involves amyloid deposition in peripheral nerves, particularly the sural and sciatic nerves, dorsal root ganglia, and sympathetic ganglia.
  • Small myelinated fibers decrease, and unmyelinated axons are depleted, with amyloid fibrils surrounding small vessels.

Related Experiment Videos

  • The amyloid fibril protein is a variant transthyretin (TTR) with specific amino acid substitutions.
  • Impact:

    • This research highlights the significant impact of TTR amyloidosis on peripheral nerve structure and function.
    • It underscores the need for further investigation into the pathogenesis of FAP neuropathy.
    • Understanding these mechanisms is vital for developing targeted therapies for FAP and related amyloid neuropathies.